| 000 | 01409 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515041332.0 | ||
| 264 | 0 | _c20080114 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gut.2006.099143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaya, D R | |
| 245 | 0 | 0 |
_aAnti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution. _h[electronic resource] |
| 260 |
_bGut _cOct 2006 |
||
| 300 |
_a1524-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aCellulitis _xchemically induced |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aEdema _xchemically induced |
| 650 | 0 | 4 |
_aFacial Pain _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xchemically induced |
| 650 | 0 | 4 |
_aGranulomatosis, Orofacial _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aAitken, S | |
| 700 | 1 | _aFennell, J | |
| 700 | 1 | _aSatsangi, J | |
| 700 | 1 | _aShand, A G | |
| 773 | 0 |
_tGut _gvol. 55 _gno. 10 _gp. 1524-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2006.099143 _zAvailable from publisher's website |
| 999 |
_c16549400 _d16549400 |
||